Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1 α maturity-onset diabetes of the young

Diabetes Care

Volumn 31, Issue 8, 2008, Pages 1496-1501

  Skupien, Jan ^a   Gorczynska Kosiorz, Sylwia ^b   Klupa, Tomasz ^a   Wanic, Krzysztof ^a   Button, Eric A ^c   Sieradzki, Jacek ^a   Malecki, Maciej T ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c BioMarker Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROSORBITOL; HEMOGLOBIN A1C; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; 1,5-ANHYDROGLUCITOL; DEOXYGLUCOSE; HNF1A PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYMATIC ASSAY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; SCREENING TEST; SENSITIVITY AND SPECIFICITY; BLOOD; GENETICS; MIDDLE AGED; MUTATION; POLAND; REFERENCE VALUE; REGISTER; SEXUAL DEVELOPMENT;

ADULT; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; MALE; MIDDLE AGED; MUTATION; POLAND; REFERENCE VALUES; REGISTRIES; SEX CHARACTERISTICS;

EID: 49649099316     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-2334     Document Type: Article

References (25)

1. Yamanouchi T, Tachibana Y, Akanuma H: Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body. Am] Physiol 263:E268-E273, 1992
2. Yamanouchi T, Shinohara T, Ogata N, Tachibana Y, Akaoka I, Miyashita H: Common reabsorption system of 1,5-an-hydro-D-glucitol, fructose, and mannose in rat renal tubule. Biochim Biophys Acta 1291:89-95, 1996
3. +-dependent uptake of 1,5-anhydro-D-glucitol via the transport systems for D-glucose and D-mannose in the kidney epithelial cell line, LLC-PK1. Nippon Jinzo Gakkai Shi 38: 435-440, 1996
4. Stickle D, Turk J: A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control. Am] Physiol 273:E821-E830, 1997
5. Yamanouchi T, Ogata N, Tagaya T, Kawasaki T, Sekino N, Funato H, Akaoka L, Miyashita H: Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet 347:1514-1518, 1996
6. Dungan KM, Buse JB, LargayJ, Kelly MM, Button EA, Kato S, Wittlin S: 1,5-Anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care 29:1214-1219, 2006
7. Kilpatrick ES, Keevilt BG, Richmond KL, Newland P, Addison GM: Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose. Diabet Med 16:496-499, 1999
8. Emoto M, TabataT, Inoue T, NishizawaY, Morii H: Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus. Nephron 61:181-186, 1992
9. Menzel R, Kaisaki PJ, Rjasanowski I, Heinke P, Kerner W, Menzel S: A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1α (HNF-1α) gene. Diabet Med 15:816 -820, 1998
10. Stride A, Ellard S, Clark P, Shakespeare L, Salzmann M, Shepherd M, Hattersley AT: β-Cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1α mutation carriers. Diabetes Care 28:1751-1756, 2005
11. Pontoglio M, Prie D, Cheret C, Doyen A, Leroy C, Froguel P, Velho G, Yaniv M, Friedlander G: HNF1α controls renal glucose reabsorption in mouse and man. EMBO Rep 1:359-365, 2000
12. Malecki MT, Skupien J, Gorczynska-Kosiorz S, Klupa T, Nazim J, Moczulski DK, Sieradzki J: Renal malformations may be linked to mutations in the hepatocyte nuclear factor-1α (MODY3) gene. Diabetes Care 28:2774-2776, 2005
13. Bochenski J, Placha G, Wanic K, Malecki M, Sieradzki J, Warram JH, Krolewski AS: New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals. Diabetes 55:2626-2630, 2006
14. Nowatzke W, Sarnob MJ, Birchc NC, Sticklec DF, Edend T, Cole TG: Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark) and determination of reference intervals on the Hitachi 917 analyzer. Clin Chim Acta 350:201-209, 2004
15. Dworacka M, Wender-Ozegowska E, Winiarska H, Borowska M, Zawiejska A, Pietryga M, Brazert J, Szczawinska K, Bobkiewicz-Kozłowska T: Plasma anhydro-D-glucitol (1,5-AG) as an indicator of hyperglycaemic excursions in pregnant women with diabetes. Diabet Med 23:171-175, 2006
16. Yamanouchi T, Akanuma Y, Toyota T, Kuzuya T, Kawai T, Kawazu S, Yoshioka S, Kanazawa Y, Ohta M, Baba S: Comparison of 1,5-anhydroglucitol, A1C, and fructosamine for detection of diabetes mellitus. Diabetes 40:52-57, 1991
17. Robertson DA, Alberti KG, Dowse GK, Zimmet P, Tuomilehto J, Gareeboo H: Is serum anhydroglucitol an alternative to the oral glucose tolerance test for diabetes screening? The Mauritius Noncommunicable Diseases Study Group. Diabet Med 10:56 -60, 1993
18. Phillipou G, James SK, Frith RG, Farrant RK, Phillips PJ: Enzymatic quantification of 1,5-anhydro-D-glucitol: evaluation and clinical application. Clin Chem 40:1322-1326, 1994
19. Monnier L, Lapinski H, Colette C: Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of A1C. Diabetes Care 26:881-885, 2003
20. Stride A, Vaxillaire M, Tuomi T, Barbetti F, Njølstad PR, Hansen T, Costa A, Conget I, Pedersen O, Søvik O, Lorini R, Groop L, Froguel P, Hattersley AT: The genetic abnormality in the β cell determines the response to an oral glucose load. Diabetologia 45:427-435, 2002
21. Stride A, Hattersley AT: Different genes, different diabetes: lessons from maturity- onset diabetes of the young. Ann Med 34:207-216, 2002
22. Pearson ER, Pruhova S, Tack CJ, Johansen A, Castleden HA, Lumb PJ, Wierzbicki AS, Clark PM, Lebl J, Pedersen O, Ellard S, Hansen T, Hattersley AT: Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4α mutations in a large European collection. Diabetologia 48:878 -885, 2005
23. Kaisaki PJ, Menzel S, Lindner T, Oda N, Rjasanowski I, Sahm J, Meincke G, Schulze J, Schmechel H, Petzold C, Ledermann HM, Sachse G, Boriraj VV, Menzel R, Kerner W, Turner RC, Yamagata K, Bell GI: Mutations in the hepatocyte nuclear factor-1α gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes 46:528-535, 1997
24. Pearson ER, Velho G, Clark P, Stride A, Shepherd M, Frayling TM, Bulman MP, Ellard S, Froguel P, Hattersley AT: β-Cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1 α and glucokinase mutations. Diabetes 50 (Suppl. 1):S101-S107, 2001
25. Iwasaki N, Oda N, Ogata M, Hara M, Hinokio Y, Oda Y, Yamagata K, Kanematsu S, Ohgawara H, Omori Y, Bell GI: Mutations in the hepatocyte nuclear factor-1α/MODY3 gene in Japanese subjects with early- and late-onset NIDDM. Diabetes 46:1504-1508, 1997